Bovine AGP antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Bovine AGP antibodies pairs and antigen for animal health (animal Bovines/Cattle Systemic Inflammation) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Ruminants disease testing products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker Information

Alpha-1 Acid Glycoprotein (AGP), when related to bovines or cattle, is a crucial biomarker for diagnosing and monitoring inflammation and various disease states in these animals. As an acute phase protein, Bovine/Cattle AGP increases in response to stress, infection, inflammation, and trauma, providing veterinarians and researchers with a valuable tool for assessing the health status of cattle.

The importance of AGP in bovine health management cannot be overstated. Its primary role as an indicator of systemic inflammation makes it a key component in the early detection of diseases that might not immediately manifest through clinical signs. Diseases such as bovine respiratory disease complex (BRDC), mastitis, and various systemic infections can significantly impact cattle health and productivity. Early detection through monitoring AGP levels allows for timely intervention, which can lead to improved outcomes and reduced economic losses.

Moreover, AGP levels in cattle serve as a reliable marker for monitoring the progression or resolution of diseases. In the context of treatment, changes in AGP levels can provide insights into the effectiveness of therapeutic interventions. A decrease in AGP concentration often indicates a positive response to treatment, whereas elevated levels may suggest ongoing inflammation or the presence of complications, guiding veterinarians in adjusting treatment protocols as necessary.

AGP also holds value as a prognostic marker in cattle. High levels of AGP at the time of diagnosis or during treatment can be associated with more severe disease states, offering prognostic insights that are crucial for making informed decisions about the management and care of affected animals. This information is particularly valuable in managing diseases with significant economic impacts, such as mastitis in dairy cattle, where decisions regarding treatment, culling, or further diagnostic investigations can have substantial economic implications.

The measurement of AGP levels in cattle is facilitated by specific assays designed for bovine serum or plasma. These diagnostic tools are essential for veterinary practitioners and researchers focusing on bovine health, enabling the accurate assessment of inflammation and disease states in cattle. The development of these assays reflects an understanding of the need for species-specific diagnostic markers in veterinary medicine and contributes to more targeted and effective disease management strategies.

In summary, Bovine/Cattle AGP plays a critical role in the field of veterinary medicine, offering a means to detect, monitor, and prognosticate health issues in cattle. Its utility in indicating the presence of inflammation and disease before the appearance of clinical symptoms allows for early intervention, potentially improving the health outcomes for cattle. Additionally, its role in monitoring treatment efficacy and disease progression enhances the ability of veterinarians to provide precise and effective care. As advancements in veterinary research continue, the potential for AGP and other biomarkers to improve the management of bovine diseases holds promise for both animal health and the agricultural industry at large.

About GDU